CPT vs TSHA · P/E 104, rev $5.3M vs $640.7M cap
Camden Property Trust (CPT) versus Taysha Gene Therapies Inc (TSHA) — a side-by-side from cached financials, not a winner call.
Camden Property Trust (CPT) is a reit - residential company listed on US.
Taysha Gene Therapies Inc (TSHA) is a biotechnology company listed on US.
Latest reported CPT revenue for 2026-06-30 was $5.3M. Net income was $61.2M. CPT currently screens at market cap $12.11B and trailing P/E 104.0.
Latest reported TSHA revenue for 2026-06-30 was $0. Net income was -$89.0M. TSHA currently screens at market cap $640.7M.
CPT currently screens at market cap $12.11B and trailing P/E 104.0. TSHA currently screens at market cap $640.7M.
Not investment advice. Open the CPT and TSHA stock pages for the full models.
Not investment advice.